IL211041A0 - Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof - Google Patents

Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

Info

Publication number
IL211041A0
IL211041A0 IL211041A IL21104111A IL211041A0 IL 211041 A0 IL211041 A0 IL 211041A0 IL 211041 A IL211041 A IL 211041A IL 21104111 A IL21104111 A IL 21104111A IL 211041 A0 IL211041 A0 IL 211041A0
Authority
IL
Israel
Prior art keywords
immunomodulatory
extracts
manufacturing
methods
lactobacillus bacteria
Prior art date
Application number
IL211041A
Other languages
English (en)
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of IL211041A0 publication Critical patent/IL211041A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL211041A 2008-09-04 2011-02-03 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof IL211041A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/010350 WO2010027344A1 (fr) 2008-09-04 2008-09-04 Extraits immunomodulateurs de bactéries lactobacillus et procédés de fabrication et d’utilisation de ceux-ci

Publications (1)

Publication Number Publication Date
IL211041A0 true IL211041A0 (en) 2011-04-28

Family

ID=41797341

Family Applications (1)

Application Number Title Priority Date Filing Date
IL211041A IL211041A0 (en) 2008-09-04 2011-02-03 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

Country Status (11)

Country Link
JP (1) JP2012502026A (fr)
KR (1) KR20110051268A (fr)
CN (1) CN102143756A (fr)
AU (1) AU2008361375B2 (fr)
BR (1) BRPI0822997A2 (fr)
CA (1) CA2733249A1 (fr)
IL (1) IL211041A0 (fr)
MX (1) MX2011002080A (fr)
RU (1) RU2500412C2 (fr)
WO (1) WO2010027344A1 (fr)
ZA (1) ZA201100899B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012103637A1 (fr) * 2011-02-02 2012-08-09 Justbio Inc. Aliments et boissons fonctionnels ayant des propriétés synergiques pour induire l'homéostase
WO2012130968A1 (fr) * 2011-03-29 2012-10-04 Nestec S.A. Dérivé naturel de la souche de lactobacillus johnsonii cncm i-1225, déficient en production d'acide d-lactique et présentant un profil immun davantage amélioré
US9309492B2 (en) * 2011-03-29 2016-04-12 Nestec S.A. Derivative of the Lactobacilus johnsonii strain CNCM I-1225, deficient in D-lactic acid production and with an improved shelf life
US20130022586A1 (en) 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
SG10202013014RA (en) 2012-01-16 2021-02-25 Mckenna Elizabeth Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
EP2898073A4 (fr) 2012-09-21 2016-03-23 Elizabeth Mckenna Compositions à base d'oligonucléotides cpg naturels et leurs utilisations thérapeutiques
US20150017208A1 (en) * 2013-07-12 2015-01-15 National Yang-Ming University Lactic acid bacterium having immunomodulatory and anti-allergic effects
JP6821643B2 (ja) * 2013-09-26 2021-01-27 雪印メグミルク株式会社 免疫疾患予防剤
JP6491422B2 (ja) * 2013-09-26 2019-03-27 雪印メグミルク株式会社 免疫疾患予防剤
CN104886255B (zh) * 2014-03-07 2018-11-27 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
KR101627806B1 (ko) * 2014-06-23 2016-06-07 한국식품연구원 락토바실러스 속 균주의 면역증강 활성을 증가시키는 배양 방법
JP6940305B2 (ja) * 2017-06-01 2021-09-22 株式会社明治 チーズ風味素材の製造方法
KR102335710B1 (ko) 2017-10-31 2021-12-07 (주)아모레퍼시픽 유산균 유래의 세포밖 베지클을 포함하는 면역조절용 조성물
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
BR112020022749A2 (pt) 2018-05-09 2021-03-02 Ko Biolabs, Inc. cepa de lactobacillus paracasei e uso da mesma
US20210220309A1 (en) * 2018-06-07 2021-07-22 National University Corporation Kanazawa University Pharmaceutical composition for prevention or treatment of kidney damage
JP7364165B2 (ja) * 2018-06-07 2023-10-18 国立大学法人金沢大学 腎障害の予防又は治療用の医薬組成物
CN109007842A (zh) * 2018-10-29 2018-12-18 广州普维君健药业有限公司 具有防治过敏功效的益生菌组合物及其应用
KR102156829B1 (ko) * 2019-02-22 2020-09-18 가톨릭대학교 산학협력단 마이크로바이옴 혼합물을 포함하는 면역 질환의 예방 및 치료용 조성물
CN109628359B (zh) * 2019-02-22 2021-03-02 江南大学 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用
EP4234026A3 (fr) 2019-03-14 2024-07-03 OM Pharma SA Procédé de fabrication d'extraits bactériens stables et leur utilisation en tant que produits pharmaceutiques
CN110643541B (zh) * 2019-10-25 2021-08-24 江南大学 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
CN111053789A (zh) * 2019-11-26 2020-04-24 湖南营养树生物科技有限公司 调节免疫系统的方法和组合物
US20230045151A1 (en) * 2020-01-13 2023-02-09 Monash University Compositions and methods
CN111548961A (zh) * 2020-05-15 2020-08-18 郑州和合生物工程技术有限公司 改善过敏性疾病的益生菌组合物、益生菌组合物菌粉及制备方法，应用
EP4161558A4 (fr) * 2020-06-06 2024-06-19 Quorum Innovations, LLC Matériaux et procédés d'inhibition d'une infection virale, comprenant une infection à coronavirus
CN111991428A (zh) * 2020-06-12 2020-11-27 郑州和合生物工程技术有限公司 一种具有改善哮喘作用的益生菌组合物及其制备方法
CN112057479B (zh) * 2020-11-16 2021-02-12 河北一然生物科技有限公司 一种能够缓解抗生素引起腹泻的益生菌组合物
KR102424594B1 (ko) * 2020-11-30 2022-07-25 파이토지노믹스 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
KR20230001127A (ko) 2021-06-28 2023-01-04 농업회사법인 산청바이오진생마을 주식회사 새싹 인삼 라떼 제조방법
KR20230131450A (ko) * 2022-03-03 2023-09-13 한국생명공학연구원 N-카바밀-l-글루탐산을 포함하는 염증성 질환의 치료용 조성물
CN114774302B (zh) * 2022-03-09 2023-06-16 善恩康生物科技（苏州）有限公司 植物乳杆菌cqpc02在制备用于预防和/或治疗狼疮性肾炎的产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532903A (fr) * 1971-06-25 1973-01-31 Nestle Sa Procédé d'extraction de protéines à partir de cellules de microorganismes
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
EP1239032A1 (fr) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Bactéries lactiques en tant qu'agents pour le traitement et la prévention des allergies
RU2302458C2 (ru) * 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Пробиотический штамм lactobacillus salivarius (варианты), пробиотический препарат на их основе и способ лечения или предупреждения с использованием штаммов lactobacillus salivarius
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
JP5224807B2 (ja) * 2004-03-04 2013-07-03 イーエルシー マネージメント エルエルシー ラクトバチルス（Ｌａｃｔｏｂａｃｉｌｌｕｓ）抽出物による皮膚の処置方法
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン１０産生促進剤

Also Published As

Publication number Publication date
AU2008361375B2 (en) 2014-05-22
WO2010027344A1 (fr) 2010-03-11
ZA201100899B (en) 2012-05-30
CN102143756A (zh) 2011-08-03
CA2733249A1 (fr) 2010-03-11
RU2011112781A (ru) 2012-10-10
JP2012502026A (ja) 2012-01-26
MX2011002080A (es) 2011-03-29
AU2008361375A1 (en) 2010-03-11
RU2500412C2 (ru) 2013-12-10
KR20110051268A (ko) 2011-05-17
BRPI0822997A2 (pt) 2015-06-23

Similar Documents

Publication Publication Date Title
IL211041A0 (en) Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
HK1145406A1 (en) Novel bacteria and methods of use thereof
HK1171474A1 (en) Novel lactobacillus plantarum and composition comprising same
EP2398494A4 (fr) Proprotéines et leurs procédés d'utilisation
EP2512369A4 (fr) Dispositifs de greffe et procédés d'utilisation
HK1173468A1 (en) Novel lactobacillus plantarum and composition comprising the same
IL213072A0 (en) Microorganism comprising particles and uses of same
PL2475764T3 (pl) Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii
EP2262450A4 (fr) Implants et procédés d utilisation
PL2271744T3 (pl) Nowy szczep lactobacillus paracasei subsp. paracasei o właściwościach przeciwbakteryjnych i immunomodulujących
ZA201300612B (en) Novel bacteria and methods of use thereof
EP2235034A4 (fr) Agents immunomodulatoires et procédés d'utilisation
IL220247A0 (en) Medical device and method of assembly
HK1149933A1 (en) Diazacarbazoles and methods of use
EP2518462A4 (fr) Capteur de force et procédé de fabrication de celui-ci
EP2402429A4 (fr) Bactérie produisant de l'équol et son utilisation
IL209548A0 (en) Diazacarbazoles and methods of use
IL214355A0 (en) Antibodies against human tweak and uses thereof
EP2419524B8 (fr) Détection des bactéries et des champignons
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
EP2444502A4 (fr) Méthode et kit de détection de bactéries produisant du gaïacol
EP2296675A4 (fr) Extraits provenant d echinodermes, procedes de preparation et utilisations associes
EP2480242A4 (fr) Lipopolysaccharide isolé de tissu de pyrularia et/ou bactérie associée à pyrularia et leurs utilisations
EP2326662A4 (fr) Glycoprotéines bactériennes mutantes et leurs utilisations
EP2494052A4 (fr) Métastructure bactérienne et procédés d'utilisation